Citi analyst Christopher Allen raised the firm’s price target on CME Group to $240 from $215 and keeps a Buy rating on the shares after meeting with management. The analyst came away “incrementally positive” given CME’s positioning to benefit from near-term and long-term tailwinds across the platform, but specifically in rates, energy and metals.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CME:
- CME Group price target raised to $240 from $224 at Deutsche Bank
- CME Group reports T-Bill futures have traded more than 6,000 contracts
- CME Group price target raised to $247 from $230 at Barclays
- CME Group achieves record volume in Aluminum futures contract in Q3
- CME Group reached ADV of 22.7M contracts in September